Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,513.82 96.29 0.67%
TOPIX 1,170.07 3.48 0.30%
HANG SENG 22,760.24 64.23 0.28%

PerkinElmer Introduces Novel Research Tools to Accelerate Discovery of More Effective Therapies for Life Threatening Diseases at



  PerkinElmer Introduces Novel Research Tools to Accelerate Discovery of More
  Effective Therapies for Life Threatening Diseases at the Society for
  Laboratory Automation and Screening (SLAS) 2014 Conference

Third Annual SLAS Conference 2014

Business Wire

SAN DIEGO -- January 20, 2014

PerkinElmer Inc., a global leader focused on the health and safety of people
and the environment, will introduce several novel products at the third Annual
Society for Laboratory Automation and Screening (SLAS) Conference (#SLAS2014)
in San Diego, January 18-22, including the Opera® Phenix™ high content
screening system, JANUS® chemagic nucleic acid workstation (Booth #1005).

PerkinElmer introduces the JANUS(R) chemagic automated nucleic acid
workstation that offers high thr ...

PerkinElmer introduces the JANUS(R) chemagic automated nucleic acid
workstation that offers high throughput DNA and RNA extraction with four times
the yield and twice the throughput of alternate technologies. A fully
integrated system, this workstation combines best-in-class magnetic bead
nucleic acid isolation technology with a fully-supported automated liquid
handler to rapidly accelerate the extraction process.

"We are excited to participate in this important event for our industry as we
continue to listen and learn from our customers, helping advance
transformative science and build upon a legacy of innovation in automation,
detection and screening solutions,” said Jim Corbett, President, Life Sciences
and Technology, PerkinElmer. "Advances in phenotyping complex cellular models
and innovations in genomics, particularly rapid, high throughput nucleic acid
extraction, offer new tools to accelerate our understanding of cancer and
other life threatening diseases, as well as enable customers to bring better,
more effective therapeutics to market."

PerkinElmer products on display at SLAS 2014 include:

  * Opera® Phenix, a next generation confocal high content screening system,
    is designed to reliably discriminate phenotypes of complex cellular
    models, such as primary cells and 3D microtissue, which are more
    indicative of human biology. Accurate, reliable characterization of
    cellular processes can further scientists’ understanding of cancer cell
    morphology and therefore the development of targeted cancer treatments.
    The system’s patented Synchony™ Optics control excitation to eliminate
    unwanted crosstalk in the sample, resulting in better sensitivity but
    without compromising speed. Data generated using the Phenix® imaging
    system can be processed seamlessly with PerkinElmer’s Harmony^® High
    Content Imaging and Analysis Software, an intuitive workflow-based
    interface optimized for processing large volumes of data.
  * The JANUS® chemagic automated nucleic acid workstation offers high
    throughput DNA and RNA extraction with four times the yield and twice the
    throughput of alternate technologies. A fully integrated system, this
    workstation combines best-in-class magnetic bead nucleic acid isolation
    technology with a fully-supported automated liquid handler to rapidly
    accelerate the extraction process. Standardized protocols are designed for
    volume ranges of 10µl up to 4mL, resulting in reproducible, high
    throughput extraction from a variety of blood input sample types for
    downstream processing including PCR/qPCR, Sanger or next gen sequencing,
    microarrays and genotyping.
  * Dedicated AlphaLISA^® immunoassay kits for isotyping human and mouse
    antibodies provide high specificity and low cross-reactivity between
    isotypes, without compromising sensitivity or throughput.
  * AlphaLISA kits and toolbox reagents for metabolic disease research with
    biomarkers including Glucagon, Insulin, Leptin, C-peptide, and FGF21
  * AlphaLISA kits for cell-based epigenetic ubiquitination which enable
    scientists to fully validate the mechanism of action of drugs thought to
    act on methyltransferase (eg. EZH2) or demethylase (eg. JMJD2A, JMJD3)
    enzymes in cell-based assays by testing their capacity to modulate H2a
    ubiquitination. These kits allow considerable time-savings over
    Enzyme-linked immunosorbent assay (ELISA) technology, commonly used to
    perform immunoassays.

The above products are for research use only and not for use in diagnostic
procedures.

  * SciStream™, new software enabling the easy import of plate-based and other
    forms of instrument data into the TIBCO Spotfire® Analytics and
    Visualization Platform. SciStream unlocks the power of TIBCO Spotfire
    software for users of plate readers, high content imaging systems and
    other instruments, enabling researchers to easily and dynamically
    visualize their experimental data, metadata and plate layouts with
    unprecedented speed and interactivity. Faster visualization and analysis
    in TIBCO Spotfire software leads to scientific insights much more quickly
    than using traditional tools for assay development as well as large
    screening campaigns.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $2.1 billion in 2012, has about 7,600 employees serving
customers in more than 150 countries, and is a component of the S&P 500 Index.
Additional information is available through 1-877-PKI-NYSE, or at
www.perkinelmer.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20140120005603/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50786089&lang=en

Contact:

PerkinElmer, Inc.
Nancy Hertig, 781-266-7459
Nancy.hertig@perkinelmer.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement